Cargando…

IP-10 Is a Potential Biomarker of Cystic Fibrosis Acute Pulmonary Exacerbations

BACKGROUND: Cystic fibrosis (CF) is characterized by acute pulmonary exacerbations (APE). The CF nasal airway exhibits a similar ion transport defect as the lung, and colonization, infection, and inflammation within the nasal passages are common among CF patients. Nasal lavage fluid (NLF) is a minim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solomon, George M., Frederick, Carla, Zhang, Shaoyan, Gaggar, Amit, Harris, Tom, Woodworth, Bradford A., Steele, Chad, Rowe, Steven M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745468/ https://www.ncbi.nlm.nih.gov/pubmed/23977293 http://dx.doi.org/10.1371/journal.pone.0072398

Ejemplares similares

Immunomodulation in Cystic Fibrosis: Why and How?
por: Giacalone, Vincent D., et al.
Publicado: (2020)

Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients
por: Garcia, Bryan A., et al.
Publicado: (2018)

Proline-Glycine-Proline (PGP) and High Mobility Group Box Protein-1 (HMGB1): Potential Mediators of Cystic Fibrosis Airway Inflammation
por: Gaggar, Amit, et al.
Publicado: (2010)

Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis
por: De Rose, Virginia, et al.
Publicado: (2018)

Acquired cystic fibrosis transmembrane conductance regulator dysfunction
por: Banks, Catherine, et al.
Publicado: (2018)

Resveratrol Enhances Airway Surface Liquid Depth in Sinonasal Epithelium by Increasing Cystic Fibrosis Transmembrane Conductance Regulator Open Probability
por: Zhang, Shaoyan, et al.
Publicado: (2013)

Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis
por: Asner, Sandra, et al.
Publicado: (2012)

Correction: Resveratrol Enhances Airway Surface Liquid Depth in Sinonasal Epithelium by Increasing Cystic Fibrosis Transmembrane Conductance Regulator Open Probability
por: Zhang, Shaoyan, et al.
Publicado: (2014)

Daily spirometry in an acute exacerbation of adult cystic fibrosis patients
por: Stephen, Michael J, et al.
Publicado: (2017)

Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study
por: Wells, J. Michael, et al.
Publicado: (2016)

Proline-Glycine-Proline as a Potential Biomarker in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis
por: ten Hoeve, Arne Lucas, et al.
Publicado: (2012)

Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
por: Zemanick, Edith T., et al.
Publicado: (2013)

Impact of exacerbations of cystic fibrosis on muscle strength
por: Burtin, Chris, et al.
Publicado: (2013)

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations
por: Merjaneh, Lina, et al.
Publicado: (2020)

Rhinovirus C and Respiratory Exacerbations in Children with Cystic Fibrosis
por: de Almeida, Marina B., et al.
Publicado: (2010)

Evaluation of Copeptin during Pulmonary Exacerbation in Cystic Fibrosis
por: Wojsyk-Banaszak, I., et al.
Publicado: (2019)

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
por: Sawant, Akhil, et al.
Publicado: (2018)

Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation
por: Hassanzad, Maryam, et al.
Publicado: (2021)

BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
por: Schultz, Andre, et al.
Publicado: (2023)

The Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC) trial: Rationale and design of a multi-center, double-blind, placebo-controlled trial of high dose bolus administration of vitamin D3 during acute pulmonary exacerbation of cystic fibrosis()
por: Tangpricha, Vin, et al.
Publicado: (2017)

Pulmonary Exacerbations in Adults With Cystic Fibrosis: A Grown-up Issue in a Changing Cystic Fibrosis Landscape
por: Stanford, Gemma E., et al.
Publicado: (2021)

Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic Fibrosis
por: Schultz, Andre, et al.
Publicado: (2019)

Glucose Tolerance during Pulmonary Exacerbations in Children with Cystic Fibrosis
por: Widger, John, et al.
Publicado: (2012)

Hospital versus home treatment of respiratory exacerbations in cystic fibrosis
por: Lavie, Moran, et al.
Publicado: (2011)

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis
por: DiMango, Emily, et al.
Publicado: (2014)

Adrenal reserve in acute exacerbation of non-cystic fibrosis bronchiectasis
por: Rajagopala, Srinivas, et al.
Publicado: (2015)

Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations
por: Skolnik, Kate, et al.
Publicado: (2018)

Virus and cystic fibrosis: Rhinoviruses are associated with exacerbations in adult patients()
por: Goffard, Anne, et al.
Publicado: (2014)

Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections
por: Pribble, Charles G., et al.
Publicado: (1990)

Urinary bicarbonate and metabolic alkalosis during exacerbations in cystic fibrosis
por: Spoletini, Giulia, et al.
Publicado: (2022)

The association of fecal calprotectin and respiratory exacerbation in cystic fibrosis patients
por: Imanzadeh, Farid, et al.
Publicado: (2022)

Smartphone-Based pH Sensor for Home Monitoring of Pulmonary Exacerbations in Cystic Fibrosis
por: Sun, Alexander, et al.
Publicado: (2017)

Management of respiratory tract exacerbations in people with cystic fibrosis: Focus on imaging
por: Landini, Nicholas, et al.
Publicado: (2023)

Biomarkers of inflammation in infants with cystic fibrosis
por: Laguna, Theresa A., et al.
Publicado: (2018)

Variation in treatment preferences of pulmonary exacerbations among Australian and New Zealand cystic fibrosis physicians
por: Currie, Grace, et al.
Publicado: (2021)

Plasma sCD14 as a Biomarker to Predict Pulmonary Exacerbations in Cystic Fibrosis
por: Quon, Bradley S., et al.
Publicado: (2014)

Metabolomic Biomarkers to Predict and Diagnose Cystic Fibrosis Pulmonary Exacerbations: A Systematic Review
por: Nguyen, Anna-Lisa V., et al.
Publicado: (2022)

The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation
por: Carmody, Lisa A, et al.
Publicado: (2015)

CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways
por: Patel, Sheylan D., et al.
Publicado: (2020)

Transcriptional firing represses bactericidal activity in cystic fibrosis airway neutrophils
por: Margaroli, Camilla, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_go5nc96arr0b25q7nuk7djalru